BioSpace News Archive

Today, Pluristyx, panCELLa, and Implant Therapeutics management are excited to announce their corporate merger, pending shareholder approval.

The latest market analysis report published by Reports and Data, titled ‘Global Bone Resorption Treatment Market – Forecast to 2030,’ thoroughly examines the Bone Resorption Treatment industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Graves Ophthalmopathy Market – Forecast to 2030,’ thoroughly examines the Graves Ophthalmopathy industry to provide essential data & information for the targeted readers.

Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) (“Satellos” or the “Corporation”), a drug discovery company aimed at developing therapeutics that regenerate muscle as a new approach to treating disease conditions from muscular dystrophy to aging, is pleased to announce that its common shares have commenced trading on the OTCQB Venture Market (“OTCQB”) under the symbol “MSCLF”.

Genetesis, the market leader in next-generation biomagnetic imaging, has announced that it has closed $17.5 million in Series C Financing.

Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that it has been granted US patent 11,400,145, entitled “Genetically modified cells and uses thereof”.

The latest market analysis report published by Reports and Data, titled ‘Global Diffuse Large B-Cell Lymphoma (DLBCL) Treatment Market – Forecast to 2030,’ thoroughly examines the Diffuse Large B-Cell Lymphoma (DLBCL) Treatment industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Hepatitis C Virus Treatment Market – Forecast to 2030,’ thoroughly examines the Hepatitis C Virus Treatment industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Phenylketonuria Treatment Market – Forecast to 2030,’ thoroughly examines the Phenylketonuria Treatment industry to provide essential data & information for the targeted readers.

The global sickle cell disease treatment market size was USD 1.70 Billion in 2021 and is expected to register a revenue CAGR of 18.1% over the forecast period, according to the latest report by Reports and Data.